Katherine Zina Isoardi

Katherine Zina Isoardi

Auto-generated profile, based on publicly available information

Katherine Zina Isoardi

Clinical Toxicology Unit Princess Alexandra Hospital Brisbane Australia

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2018 in Emergency Medicine Australasia
Verified
Journal Article
Closed access
PDF file
KIKatherine Z Isoardi
Katherine Z Isoardi
SASarah F Ayles
Sarah F Ayles
KHKeith Harris
Keith Harris
CFClare J Finch
Clare J Finch
CPColin B Page
Colin B Page

6 May 2020 in British Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
KIKatherine Z. Isoardi
Katherine Z. Isoardi
GPGregory Polkinghorne
Gregory Polkinghorne
KHKeith Harris
Keith Harris
Geoffrey IsbisterGeoffrey Isbister
Geoffrey Isbister

12 August 2021 in Emergency Medicine Australasia
Verified
Journal Article
Closed access
PDF file
JSJennifer L Smith
Jennifer L Smith
JSJessamine Soderstrom
Jessamine Soderstrom
ADAndrew Dawson
Andrew Dawson
SASam Alfred
Sam Alfred
SGShaun Greene
Shaun Greene
TIthe EDNA Investigators
the EDNA Investigators

30 July 2021 in Clinical Toxicology
Verified
Journal Article
Open access
TNTina Noutsos
Tina Noutsos
BCBart Currie
Bart Currie
KIKatherine Z. Isoardi
Katherine Z. Isoardi
SBSimon G. A. Brown
Simon G. A. Brown
Geoffrey IsbisterGeoffrey Isbister
Geoffrey Isbister
Snakebite-associated thrombotic microangiopathy (TMA) occurs in a subset of patients with venom-induced consumption coagulopathy (VICC) following snakebite. Acute kidney injury (AKI) is the commone...

28 July 2020 in Nephrology
Verified
Journal Article
Closed access
PDF file
KIKatherine Z. Isoardi
Katherine Z. Isoardi
DMDavid William Mudge
David William Mudge
KHKeith Harris
Keith Harris
GDGoce Dimeski
Goce Dimeski
NBNicholas A. Buckley
Nicholas A. Buckley

7 December 2018 in Prehospital Emergency Care
Verified
Journal Article
Closed access
CPColin B. Page
Colin B. Page
LPLachlan E. Parker
Lachlan E. Parker
SRStephen J. Rashford
Stephen J. Rashford
KIKatherine Z. Isoardi
Katherine Z. Isoardi
Geoffrey IsbisterGeoffrey Isbister
Geoffrey Isbister
Study objective: Although uncommon, children (<16 years) with acute behavioral disturbance are a significant issue for emergency medical service providers. In this study, we aimed to investigate the safety and effectiveness of droperidol in children with prehospital acute behavioral disturbance. Methods: This was a prospective observational study over 1 year investigating the use of droperidol (0.1-0.2 mg/kg) for children (< 16 years) with acute behavioral disturbance. Inclusion criteria for acute behavioral disturbance were defined by a sedation assessment tool score of ≥2 determined by the attending paramedic. The primary outcome was the proportion of adverse effects (need for airway intervention, oxygen saturation <90% and/or respiratory rate <12, systolic blood pressure <90 mmHg, sedation assessment tool score of -3 and dystonic reactions). Secondary outcomes included time to sedation (sedation assessment tool score decreased by 2 or more, or a score of zero), requirement for additional sedation, failure to sedate and proportion of sedation success defined as the number of patients successfully sedated who did not suffer any adverse events or receive additional sedation. Results: There were 96 patients (males 51 [53%], median age 14 years [range 7-15 years]) who presented on 102 occasions over the one year study period. Self-harm and/or harm to others was the commonest (74/105 [70%]) cause of acute behavioral disturbance followed by alcohol (16/105 [15%]). There were 9 adverse events in 8 patients (8/102 [8%]; 95% confidence intervals [CI]: 3-13%) Five patients had hypotension, all asymptomatic and only one required treatment; 2 dystonic reactions managed with benztropine and one patient with respiratory depression. Median time to sedation was 14 min (interquartile range (IQR): 10-20 min; range: 3-85 min). There was no requirement for prehospital additional sedation (0/102 [0%]; 95% CI: 0-4%) and additional sedation in the first hour of arrival to hospital was required by 4 patients (4/102 [4%]; 95% CI: 1-10%). Overall successful sedation was achieved in 89 (87%) patients. Conclusions: The use of droperidol in children for acute behavioral disturbance in the prehospital setting is both safe and effective.